Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1975-07-30
1978-02-14
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260413, 260511D, 260557R, 260586R, 260617R, 26034846, 26034855, 424305, 560121, 560231, C07C17700, A61K 31215
Patent
active
040739384
ABSTRACT:
The invention relates to 19,20-bis-nor-prostanoic acids, and their functional derivatives, endowed with hypolipemic, and antiulcerous properties.
REFERENCES:
Valcavi, Il Farmaco, 27, 610, (1972).
Valcavi et al., Il Farmaco, 30, 527, (1975).
Dr. Madaus & Co.
Gerstl Robert
Istituto Biochimico Italiano di Loredana Lorenzini S.a.s.
LandOfFree
19,20-Bis-nor-prostenoic acids as hypolipemic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 19,20-Bis-nor-prostenoic acids as hypolipemic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 19,20-Bis-nor-prostenoic acids as hypolipemic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-524963